[Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D010450:Endopeptidases / Q000008:administration & dosage*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005921:Glomerulonephritis / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage* / Q000627:therapeutic use
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator